A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

Just because you can buy a medication over the counter doesn’t mean it’s always safe. Here’s how you should really be using ...

DelveInsight's Artificial Kidney Market Insights report provides the current and forecast market analysis, individual leading ...

In a remarkable display of market confidence, VATE stock has surged to a 52-week high, with shares trading at an impressive $13.31, representing a dramatic 309% increase from its 52-week low of $3.25.

President Donald Trump has signed a new executive order to establish a Make America Healthy Again Commission, just hours ...

Primary Biliary Cholangitis Clinical Trial Pipeline Pharmaceutical companies are advancing the Primary Biliary Cholangitis treatment pipeli ...